• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶栓治疗在心肌梗死风险指数预测ST段抬高型心肌梗死合并多支血管病变患者长期预后中的应用:一项单中心前瞻性观察队列研究。

Application of thrombolysis in myocardial infarction risk index in the prediction of long-term outcomes for patients with ST-elevation myocardial infarction and multiple vessel disease: A single-center prospective observational cohort study.

作者信息

Fan Xuefang, Li Mingliang, Cao Jie, Liang Zeming

机构信息

Department of Cardiology, Xianyang Hospital of Yan'an University, Xianyang, Shanxi 712000, P.R. China.

Ward No. 2, Department of Cardiovascular Disease, People's Hospital of Hanzhong City, Hanzhong, Shanxi 723000, P.R. China.

出版信息

Exp Ther Med. 2021 Dec;22(6):1464. doi: 10.3892/etm.2021.10899. Epub 2021 Oct 20.

DOI:10.3892/etm.2021.10899
PMID:34737804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8561768/
Abstract

The thrombolysis in myocardial infarction (TIMI) risk index has been indicated to be a simple and useful tool for risk stratification of patients with ST-elevation myocardial infarction (STEMI). However, the predictive value of the TIMI risk index regarding the long-term outcome for patients with STEMI with multiple vessel disease has remained to be determined. In the present study, a total of 369 patients diagnosed with STEMI who received emergency percutaneous coronary intervention treatment were analyzed. A five-year follow-up was performed to record the primary endpoint of all-cause mortality, as well as the secondary endpoints of myocardial infarction, stroke, emergent revascularization and admission due to heart failure. A receiver operating characteristic (ROC) curve was used to determine the cut-off value of the TIMI risk index for predicting all-cause death, based on which the patients were divided into a high TIMI group and a low TIMI group. Kaplan-Meier survival curves were used to compare the long-term survival of the two groups and multivariate Cox regression analysis was used to evaluate the predictive value of the risk factors regarding primary and secondary endpoints. The ROC curve indicated that the TIMI risk index was associated with three-year all-cause death with a cut-off value of 30.35 (area under curve, 0.705; P=0.001). The high TIMI group (>30.35) and low TIMI group (<30.35) exhibited a significant difference in all-cause death (P=0.009) but not in any of the secondary endpoints (P=0.527). Multivariate Cox regression analysis demonstrated that a high TIMI risk index was an independent risk factor for all-cause death in patients with STEMI and multiple-vessel disease (hazard ratio=3.709, 95% CI: 1.521-9.046, P=0.004). In conclusion, the TIMI risk index was associated with long-term outcomes for patients with STEMI and multiple-vessel disease and may be of value for risk prediction.

摘要

心肌梗死溶栓(TIMI)风险指数已被证明是对ST段抬高型心肌梗死(STEMI)患者进行危险分层的一种简单且有用的工具。然而,TIMI风险指数对于多支血管病变的STEMI患者长期预后的预测价值仍有待确定。在本研究中,共分析了369例诊断为STEMI并接受急诊经皮冠状动脉介入治疗的患者。进行了为期五年的随访,以记录全因死亡率这一主要终点,以及心肌梗死、中风、急诊血运重建和因心力衰竭入院这些次要终点。采用受试者工作特征(ROC)曲线来确定TIMI风险指数预测全因死亡的临界值,并据此将患者分为高TIMI组和低TIMI组。采用Kaplan-Meier生存曲线比较两组的长期生存率,并采用多因素Cox回归分析评估危险因素对主要和次要终点的预测价值。ROC曲线表明,TIMI风险指数与三年全因死亡相关,临界值为30.35(曲线下面积,0.705;P=0.001)。高TIMI组(>30.35)和低TIMI组(<30.35)在全因死亡方面存在显著差异(P=0.009),但在任何次要终点方面均无差异(P=0.527)。多因素Cox回归分析表明,高TIMI风险指数是多支血管病变的STEMI患者全因死亡的独立危险因素(风险比=3.709,95%CI:1.521-9.046,P=0.004)。总之,TIMI风险指数与多支血管病变的STEMI患者的长期预后相关,可能对风险预测有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/b996d15f4b99/etm-22-06-10899-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/3bb93ff03bf1/etm-22-06-10899-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/9ba73bba3205/etm-22-06-10899-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/342e81291be6/etm-22-06-10899-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/48b24c7ab5df/etm-22-06-10899-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/b996d15f4b99/etm-22-06-10899-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/3bb93ff03bf1/etm-22-06-10899-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/9ba73bba3205/etm-22-06-10899-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/342e81291be6/etm-22-06-10899-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/48b24c7ab5df/etm-22-06-10899-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997e/8561768/b996d15f4b99/etm-22-06-10899-g04.jpg

相似文献

1
Application of thrombolysis in myocardial infarction risk index in the prediction of long-term outcomes for patients with ST-elevation myocardial infarction and multiple vessel disease: A single-center prospective observational cohort study.溶栓治疗在心肌梗死风险指数预测ST段抬高型心肌梗死合并多支血管病变患者长期预后中的应用:一项单中心前瞻性观察队列研究。
Exp Ther Med. 2021 Dec;22(6):1464. doi: 10.3892/etm.2021.10899. Epub 2021 Oct 20.
2
Fibrinogen-to-albumin ratio predicts long-term outcomes for patients with ST-elevation myocardial infarction and multivessel disease: A prospective observational cohort study.纤维蛋白原与白蛋白比值可预测ST段抬高型心肌梗死合并多支血管病变患者的长期预后:一项前瞻性观察队列研究。
Exp Ther Med. 2021 May;21(5):465. doi: 10.3892/etm.2021.9896. Epub 2021 Mar 8.
3
[Impact of inflammatory reaction levels and culprit plaque characteristics on preprocedural thrombolysis in myocardial infarction flow grade in patients with ST-segment elevation myocardial infarction].[炎症反应水平及罪犯斑块特征对ST段抬高型心肌梗死患者术前溶栓后心肌梗死血流分级的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2021 Feb 24;49(2):150-157. doi: 10.3760/cma.j.cn112148-20200531-00452.
4
Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者单核细胞与高密度脂蛋白胆固醇比值升高与心肌梗死溶栓治疗(TIMI)风险评分相关。
Rev Port Cardiol (Engl Ed). 2018 Mar;37(3):217-223. doi: 10.1016/j.repc.2017.06.021. Epub 2018 Mar 31.
5
Additive prognostic value of left ventricular ejection fraction to the TIMI risk score for in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.左心室射血分数对ST段抬高型心肌梗死患者院内及长期死亡率的TIMI风险评分的附加预后价值。
J Thromb Thrombolysis. 2017 Jan;43(1):1-6. doi: 10.1007/s11239-016-1407-7.
6
Use of TIMI Risk Index as a Simple and Valuable Prognostic Tool in Patients with ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.TIMI 风险指数在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中的应用:一种简单而有价值的预后工具。
Turk Kardiyol Dern Ars. 2022 Apr;50(3):192-201. doi: 10.5543/tkda.2022.21143.
7
Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.经皮冠状动脉介入治疗 TIMI 血流对 ST 段抬高和非 ST 段抬高心肌梗死患者预后的影响:来自 FAST-MI 2010 注册研究的结果。
Arch Cardiovasc Dis. 2018 Feb;111(2):101-108. doi: 10.1016/j.acvd.2017.04.004. Epub 2017 Sep 19.
8
Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial).心肌梗死溶栓风险评分对左心室功能不全的ST段抬高型心肌梗死患者的预后价值(来自EPHESUS试验)
Am J Cardiol. 2016 Nov 15;118(10):1442-1447. doi: 10.1016/j.amjcard.2016.08.004. Epub 2016 Aug 22.
9
TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.TIMI风险评分能准确预测接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者在30天和1年随访期内的死亡风险。
Kardiol Pol. 2007 Jul;65(7):788-95; discussion 796-7.
10
Favorable factors for the survival of ST-segment elevation myocardial infarction patients with medium- and high-risk thrombolysis in myocardial infarction scores.有利于中高危溶栓治疗心肌梗死评分的 ST 段抬高型心肌梗死患者的生存因素。
BMC Cardiovasc Disord. 2023 Dec 13;23(1):614. doi: 10.1186/s12872-023-03628-7.

本文引用的文献

1
[Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].[心肌梗死溶栓风险指数与接受经皮冠状动脉介入治疗的急性心肌梗死患者冠状动脉病变严重程度及长期预后的关系]
Zhonghua Xin Xue Guan Bing Za Zhi. 2018 Nov 24;46(11):874-881. doi: 10.3760/cma.j.issn.0253-3758.2018.11.011.
2
Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.比较SYNTAX评分II、SYNTAX评分和TIMI风险评分预测ST段抬高型心肌梗死患者住院及长期死亡率的疗效
Int J Cardiovasc Imaging. 2018 Aug;34(8):1165-1175. doi: 10.1007/s10554-018-1333-1. Epub 2018 Mar 14.
3
Accuracy of the TIMI and GRACE scores in predicting coronary disease in patients with non-ST-elevation acute coronary syndrome.TIMI和GRACE评分在预测非ST段抬高型急性冠状动脉综合征患者冠心病方面的准确性。
Rev Port Cardiol (Engl Ed). 2018 Jan;37(1):41-49. doi: 10.1016/j.repc.2017.05.012. Epub 2018 Feb 1.
4
Comparison of RISK-PCI, GRACE, TIMI risk scores for prediction of major adverse cardiac events in patients with acute coronary syndrome.急性冠状动脉综合征患者中RISK-PCI、GRACE、TIMI风险评分对主要不良心脏事件预测的比较。
Croat Med J. 2017 Dec 31;58(6):406-415. doi: 10.3325/cmj.2017.58.406.
5
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理指南:欧洲心脏病学会(ESC)ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
6
Comparing HEART, TIMI, and GRACE scores for prediction of 30-day major adverse cardiac events in high acuity chest pain patients in the emergency department.比较HEART、TIMI和GRACE评分对急诊科高敏胸痛患者30天主要不良心脏事件的预测价值。
Int J Cardiol. 2016 Oct 15;221:759-64. doi: 10.1016/j.ijcard.2016.07.147. Epub 2016 Jul 10.
7
Timing of Staged Percutaneous Coronary Intervention for a Non-Culprit Lesion in Patients With Anterior Wall ST Segment Elevation Myocardial Infarction With Multiple Vessel Disease.前壁ST段抬高型心肌梗死合并多支血管病变患者非罪犯病变分期经皮冠状动脉介入治疗的时机
Int Heart J. 2016 Jul 27;57(4):417-23. doi: 10.1536/ihj.15-402. Epub 2016 Jun 29.
8
The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者中,TIMI风险指数与SYNTAX和Gensini风险评分在预测冠状动脉疾病范围及严重程度方面的关系。
Ther Adv Cardiovasc Dis. 2015 Oct;9(5):257-66. doi: 10.1177/1753944715574814. Epub 2015 Mar 16.
9
Neutrophil-to-lymphocyte ratio (NLR) predicts mortality and adverse-outcomes after ST-segment elevation myocardial infarction in Chinese people.在中国人群中,中性粒细胞与淋巴细胞比值(NLR)可预测ST段抬高型心肌梗死后的死亡率和不良结局。
Int J Clin Exp Pathol. 2014 Jun 15;7(7):4045-56. eCollection 2014.
10
Additive prognostic value of the SYNTAX score over GRACE, TIMI, ZWOLLE, CADILLAC and PAMI risk scores in patients with acute ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.在接受直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者中,SYNTAX 评分优于 GRACE、TIMI、ZWOLLE、CADILLAC 和 PAMI 风险评分的附加预后价值。
Int J Cardiovasc Imaging. 2013 Aug;29(6):1215-28. doi: 10.1007/s10554-013-0202-1. Epub 2013 Feb 27.